¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Toxic effect of other specified substances"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • greenhouse effect
    ¿Â½ÇÈ¿°ú
  • healthy worker effect
    °Ç°­±Ù·ÎÀÚÈ¿°ú
  • halo effect
    ´Þ¹«¸®È¿°ú
  • isotopic effect
    µ¿À§¿ø¼ÒÈ¿°ú
  • inflow effect
    À¯ÀÔÈ¿°ú
  • inotropic effect
    ¼öÃàÃËÁøÈ¿°ú
  • late effect
    ¸¸±âÈ¿°ú
  • latitude effect
    À§µµÈ¿°ú
  • masking effect
    ÀºÆóÈ¿°ú
  • mass effect
    µ¢ÀÌÈ¿°ú, Á¾±«È¿°ú
  • mesomeric effect
    °ø¸íÈ¿°ú
  • magnetic field effect
    ÀÚÀåÈ¿°ú
  • no-observed-effect level
    ¹«°üÂûÈ¿°ú¼öÁØ
  • on-off effect
    °³½ÃÁ¾·áÈ¿°ú
  • osmolality effect
    ¸ô¶ö»ïÅõ¾ÐÈ¿°ú
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • toxic neuritis
    µ¶¼º½Å°æ¿°
  • toxic epidermal necrolysis
    µ¶¼ºÇ¥ÇDZ«»ç¿ëÇØ
  • toxic peripheral neuropathy
    µ¶¼º¸»ÃʽŰ溴Áõ
  • toxic psychosis
    µ¶¼ºÁ¤½Åº´
  • toxic reaction
    µ¶¹ÝÀÀ, Áßµ¶¹ÝÀÀ
  • toxic retinopathy
    Áßµ¶¸Á¸·º´Áõ
  • toxic chemical regulation
    µ¶¼ºÈ­Çй°Áú±ÔÁ¤
  • toxic shock
    µ¶¼º¼îÅ©
  • toxic stomatitis
    µ¶¼ºÀԾȿ°, µ¶¼º±¸³»¿°
  • toxic substance
    µ¶¼º¹°Áú
  • toxic shock syndrome
    µ¶¼ÒÃæ°ÝÁõÈıº
  • toxic
    µ¶¼º-, Áßµ¶-
  • toxic tolerance
    µ¶¹°³»¼º
  • acute normal tissue effect
    Á¤»óÁ¶Á÷±Þ¼º¿µÇâ
  • additive effect
    ºÎ°¡È¿°ú, »ó°¡È¿°ú
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • anticoagulant effect
    Ç×ÀÀ°íÈ¿°ú.
  • anticurare effect
    Ç×Å¥¶ó·¹ÀÛ¿ë.
  • antioxidant effect
    Ç×»êÈ­È¿°ú(¡­üùÍý).
  • antitoxemic effect
    Ç×µ¶Ç÷ÁõÈ¿°ú.
  • antitussive effect
    ÁøÇØÈ¿°ú(òåú¦üùÍý).
  • glucose effect
    Æ÷µµ´çÈ¿°ú
  • gradient induced phase shift effect
    °æ»ç À¯µµ À§»ó º¯À§ È¿°ú
  • green house effect
    ¿Â½ÇÈ¿°ú
  • halo effect
    ´Þ¹«¸® È¿°ú
  • hearing, binaural (effect)
    ¾çÀÌû(È¿°ú)
  • heat effect
    ¿­È¿°ú
  • heel effect
    µÚÃàÈ¿°ú, µÚ²Þġȿ°ú
  • hepatic first pass effect
    °£ÃÊȸÅë°úÈ¿°ú.
  • hereditary effect
    À¯ÀüÀû¿µÇâ
  • immediate effect
    Áï(°¢)È¿(°ú), Áï½ÃÈ¿°ú.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • toxic action
    µ¶ÀÛ¿ë(Ô¸íÂéÄ).
  • toxic agent
    µ¶¹°.
  • toxic alopecia
    µ¶¼º Å»¸ð(Áõ)
  • toxic amaurosis
    Áßµ¶¼ºÈæ³»Àå(¡­ýÙÒ®íô)
  • toxic amblyopia
    Áßµ¶¾à½Ã(¡­å°ãÊ).
  • toxic anemia
    Áßµ¶¼ººóÇ÷(ñéÔ¸àõÞ¸úì)
  • toxic asthma
    Áßµ¶¼ºÃµ½Ä(ñéÔ¸àõô·ãÓ)
  • toxic atrophy
    Áßµ¶¼ºÀ§Ãà(ñéÔ¸àõê×õê)
  • toxic cardiopathy
    Áßµ¶¼º½ÉÀ庴Áõ
  • toxic cataract
    Áßµ¶¹é³»Àå(¡­ÛÜÒ®î¡).
  • toxic cataract
    Áßµ¶¼º¹é³»Àå(¡­ÛÜÒ®î¡)
  • toxic chemical regulation
    µ¶¼ºÈ­Çй°Áú±ÔÁ¤
  • toxic chemical use
    µ¶¼ºÈ­Çй°ÁúÀÌ¿ë
  • toxic conjunctivitis
    Áßµ¶°á¸·¿°
  • toxic convulsion
    Áßµ¶¼º°æ·Ã(¡­ÌâÕý)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • hypochromic effect
    Èí±¤ °¨¼Ò È¿°ú(ýåÎÃÊõá´üùÍý)
  • induction effect
    À¯µµÈ¿°ú(ë¯ÓôüùÍý)
  • inductive effect
    À¯µµÈ¿°ú(ë¯ÓôüùÍý)
  • isotope effect
    µ¿À§¿ø¼Ò È¿°ú(ÔÒêÈêªáÈüùÍý)
  • Johnston-Ogston effect
    ÁÔ½ºÅæ-¿À±×½ºÅæ È¿°ú(üùÍý)
  • kerr effect
    Äɸ£ È¿°ú(üùÍý)
  • kinetic isotope effect
    ¹ÝÀÀ¼Óµµ(ÚãëëáÜÓø) µ¿À§¿ø¼ÒÈ¿°ú(ÔÒêÈêªáÈüùÍý)
  • linear electric field effect
    ¼±Çü Àü±âÀåÈ¿°ú(àÊû¡ï³Ñ¨íÞüùÍý)
  • Maxwell effect
    ¸ß½º¿¤ È¿°ú(üùÍý)
  • meiotic effect
    °¨¼öºÐ¿­ È¿°ú(Êõâ¦ÝÂÖ®üùÍý)
  • neighboring group effect
    ±ÙÁ¢±â È¿°ú(ÐÎïÈÐïüùÍý)
  • oligodynamic effect
    ¹Ì·®ÀÛ¿ëÈ¿°ú(Ú°ÕáíÂéÄüùÍý)
  • opsonic effect
    ¿É¼Ò´Ñ È¿°ú(üùÍý)
  • orientation effect
    Á¤À§ È¿°ú(ïÒêÈüùÍý)
  • Pasteur effect
    ÆÄ½ºÅ𸣠ȿ°ú(üùÍý)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • piezoelectric effect
    ¾ÐÀüÈ¿°ú
  • radiation effect
    ¹æ»ç¼±È¿°ú
  • radio-frequency thermal effect
    °íÁÖÆÄ¿­È¿°ú
  • reverse piezoelectric effect
    ¿ª¾ÐÀüÈ¿°ú
  • RF antennae effect
    °íÁ֯ľÈÅ׳ªÈ¿°ú
  • shielding effect
    Â÷ÆóÈ¿°ú
  • siphonage effect
    ½ÎÀÌÆùÈ¿°ú
  • spatial presaturation effect
    °ø°£ÀüÆ÷È­È¿°ú
  • spin phase effect
    ½ºÇÉÀ§»óÈ¿°ú
  • T1 shortening effect
    T1´ÜÃàÈ¿°ú
  • T2 shortening effect
    T2´ÜÃàÈ¿°ú
  • volume averaging effect
    ¿ëÀûÆò±ÕÈ­È¿°ú
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
CSA Canadian Standards Association; canavaninosuccinic acid; carbonyl salicylamide; cell surface antigen...
CSIN Chemical Substances Information Network
EINECS European Inventory of Existing Commercial Chemical Substances
HSA Hazardous Substances Act; Health Services Administration; health systems agency; hereditary siderobl...
HSDB hazardous substances data bank
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
OND other neurologic disease
TBARS 2-Thiobarbituric acid-reactive substances
TBARS 2-thiobarbituric reactive substances
BGS Blood group substances
EPS Extracellular polymeric substances
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • carriar effect
    ´ãü È¿°ú
    Ha
  • carry effect
    ¿î¹Ý È¿°ú
  • cavitation effect
    °øµ¿ È¿°ú
  • clasp knife effect
    Á¢´Â Ä® È¿°ú
  • cytopathogenic effect
    ¼¼Æ÷ º¯¼º Çö»ó, ¼¼Æ÷ º´º¯ È¿°ú
  • Deelman`s effect
    µ¨¸¸ È¿°ú
  • detergent effect
    Á¤È­ ÀÛ¿ë
  • domino effect
    µµ¹Ì³ë È¿°ú
  • Donnan effect
    µµ³­ È¿°ú
  • Doppler effect
    µµÇ÷¯ È¿°ú, Doppler È¿°ú
    1. ±Ù¿øÁö¿¡ ´ëÇÑ ¼ö½ÅÁöÀÇ »ó´ëÀûÀÎ ¿îµ¿À¸·ÎºÎÅÍ ¾ß±âµÇ´Â Á֯ļöÀÇ ¸í¹éÇÑ º¯È­. 2. ¾î¶² ¹°Ã¼°¡ ¿îµ¿ »óÅ¿¡ ÀÖÀ» ¶§ ³ªÅ¸³ª´Â ¹ÝÇâµÇ´Â ¹æ»ç¼±¿¡¼­ Áøµ¿¼öÀÇ º¯È­´Â µµÇ÷¯ È¿°úÀÇ °á°úÀÌ´Ù. ¹æ»ç¼±ÀÇ ±Ù¿øÀ¸·ÎºÎÅÍ ¶³¾îÁø ¹°Ã¼ÀÇ ¿îµ¿Àº Á¤Áö »óÅÂÀÇ ¹°Ã¼¿¡ ºñ±³ÇØ º¼ ¶§ ´õ ³·Àº Áøµ¿¼öÀÇ ¹ÝÇâÀ» ÀÏÀ¸Å³ °ÍÀÌ´Ù. ¹æ»ç¼±ÀÇ ±Ù¿øÀ» ÇâÇÑ ¿îµ¿Àº ´õ ³ôÀº Áøµ¿¼ö¸¦ ÀÏÀ¸Å²´Ù.
  • dose rate effect
    ¼±·®À² È¿°ú
  • dose-effect relationship
    ¼±·® ¿µÇâ °ü°è
  • double effect
    ÀÌÁß È¿°ú
  • drug side effect
    ºÎÀÛ¿ë
  • efferent effect
    ¿ø½É È¿°ú
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
toxic nephrosis Acute oliguric renal failure due to chemical poisons, septicaemia, or bacterial toxaemia; frequently associated with extensive necrosis of proximal convoluted tubules.
(05 Mar 2000)
toxic neuritis Neuritis caused by an endogenous or exogenous toxin.
(05 Mar 2000)
toxic nodular goitre <endocrinology> An enlarged thyroid gland which contains nodules which release excess thyroid hormone. This condition usually arises from long-standing simple goitre in the elderly.
Symptoms of hyperthyroidism result.
(12 Jan 1998)
toxic psychosis A psychosis caused by some toxic substance, whether endogenous or exogenous.
(05 Mar 2000)
toxic retinopathy Retinal changes due to prolonged administration of various drugs.
(05 Mar 2000)
toxic shock See toxic shock syndrome.
(12 Dec 1998)
toxic shock syndrome <syndrome> A blood-borne bacterial infection caused by the genus Staphylococcus. Usually effects menstruating females under the age of thirty and was associated in the past with the use of a particular type of tampon (no longer used).
Common symptoms include: fever, chills, vomiting, sore throat, headache and decreased urine output. Progression of disease can result in lowering of blood pressure (shock) and renal failure.
Treatment includes hospitalisation and intravenous antibiotics emergently.
(27 Sep 1997)
toxic tetanus Tonic spasms caused by strychnine or other tetanic.
Synonym: toxic tetanus.
(05 Mar 2000)
toxic unit A unit formerly synonymous with minimal lethal dose but which, because of the instability of toxins, is now measured in terms of the quantity of standard antitoxin with which the toxin combines.
See: L doses, minimal lethal dose.
Synonym: toxin unit.
(05 Mar 2000)
epidermal necrolysis, toxic An exfoliative disease of skin seen primarily in adults and characterised by flaccid bullae and spreading erythema so that the skin has the appearance of being scalded. It results primarily from a toxic reaction to various drugs, but occasionally occurs as a result of infection, neoplastic conditions, or other exposure.
(12 Dec 1998)
abscopal effect A reaction produced following irradiation but occurring outside the zone of actual radiation absorption.
(05 Mar 2000)
additive effect <biochemistry, chemistry> An additive effect is the overall biological effect two chemicals acting together and which is the simple sum of the effects of the chemicals acting independently.
Compare: antagonism.
(15 Jan 1998)
adverse effect This is an abnormal or harmful effect to an organism caused by exposure to a chemical. It is indicated by some result such as death, a change in food or water consumption, altered body and organ weights, altered enzyme levels, or visible illness. An effect may be classed as adverse if it causes functional or anatomical damage, causes irreversible change in the homeostasis of the organism, or increases the susceptibility of the organism to other chemical or biological stress. A non-adverse effect will usually be reversed when the organism is no longer being exposed to the chemical.
(09 Oct 1997)
Anrep effect A small transient positive inotropic effect of abrupt increases of systolic aortic and left ventricular pressures related to recovery from transient subendocardial ischemia (e.g., cold pressor test).
(05 Mar 2000)
antagonistic effect This is the consequence of one chemical (or group of chemicals) counteracting the effects of another chemical, the opposing chemicals cancel out each other's effects.
(09 Oct 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • photoelectric effect
    ±¤ÀüÈ¿°ú
  • ram effect
    ·¥ È¿°ú(±â¼Ó)ÀÇ Áõ°¡¿¡ µû¶ó ÈíÀÔ±¸¿¡ À¯ÀԵǴ °ø±âÀÇ ¾Ð·ÂÀÌ Áõ°¡ÇÏ´Â È¿°ú) '
  • ratchet effect
    ´Ü¼ÓÀû È¿°ú 
  • ripple effect
    ÆÄ±Þ È¿°ú !
  • shot effect,the
    (Áø°ø°üÀÇ À½±Ø¿¡¼­ ¹æ»çµÇ´Â ¿­ÀüÀÚÀÇ)»êź È¿°ú ''
  • side effect
    ºÎÀÛ¿ë
  • skin effect
    (Á֯ļö ÀüµµÃ¼ÀÇ)Ç¥ÇÇ È¿°ú
  • stage effect
    ¹«´ë È¿°ú
  • tunnel effect
    ÅͳΠȿ°ú !
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á